WHO and Switzerland Cement Strategic Partnership Through 2028 to Advance Public Health Leadership and Innovation

The World Health Organization (WHO) and the Swiss Confederation have officially cemented their long-standing partnership by renewing their joint cooperation strategy for the 2024–2028 period. Formalized during a high-level meeting at the WHO Regional Office for Europe in Copenhagen, Denmark, the renewed framework builds upon more than a decade of institutional collaboration. The agreement was officially signed by Dr. Hans Henri P. Kluge, WHO Regional Director for Europe, and Barbara Schedler, Ambassador for Global Health at the Swiss Federal Office of Public Health.

This strategic renewal marks a significant milestone in European and global public health governance. Switzerland originally made history in 2013 by becoming the first high-income country within the WHO European Region to pilot a formal country cooperation strategy with the global health body. Over the past decade, this pioneering framework has served as a benchmark for how wealthy nations can effectively align their domestic public health capacities, foreign policy objectives, and financial resources with multilateral health agendas.

The decision to update and extend the agreement was initially reached in 2022, following comprehensive joint evaluations that highlighted both the evolving landscape of post-pandemic global health security and the increasing complexity of chronic and emerging health threats. By formalizing the strategy through 2028, both parties have committed to tackling systemic health vulnerabilities, bolstering regional preparedness, and driving forward innovations in global health architecture.

Historical Context and Evolution of the Partnership

The relationship between Switzerland and the World Health Organization is deeply rooted in geography, diplomacy, and shared humanitarian values. As the host country for WHO’s global headquarters in Geneva, Switzerland has historically functioned as a vital nexus for international health policy discussions, negotiations, and standard-setting initiatives.

When the initial country cooperation strategy was launched in 2013, the primary objective was to establish a structured, programmatic approach to Switzerland’s engagement with the WHO European Region. Historically, high-income countries rarely utilized country cooperation strategies, which were traditionally designed to support low- and middle-income nations in strengthening their health systems. However, Switzerland recognized the strategic value of creating a formalized, transparent bilateral roadmap to optimize its contributions to European public health and leverage its domestic technical expertise on an international scale.

Over the subsequent ten years, the scope of cooperation expanded significantly. The partnership moved beyond traditional infectious disease surveillance to encompass a wide array of public health priorities, including universal health coverage, non-communicable diseases (NCDs), antimicrobial resistance (AMR), health workforce strengthening, and digital health transformation. The success of these collaborative efforts laid the necessary groundwork for the 2022 decision to review, modernize, and extend the framework for another five-year cycle.

Chronology of Key Milestones

The formalization of the 2024–2028 strategy represents the culmination of a multi-year collaborative process between Swiss authorities and WHO officials:

• 2013: Switzerland becomes the first high-income country in the WHO European Region to pilot and adopt a formal Country Cooperation Strategy (CCS), setting a new precedent for high-income nation engagement with multilateral health agencies.
• 2018–2019: Mid-term evaluations of the initial cooperation framework demonstrate significant alignment in technical capacities, particularly in health security and emergency response protocols.
• 2022: Following the severe global disruptions caused by the COVID-19 pandemic, WHO and Swiss federal authorities jointly decide to update, expand, and renew the cooperation strategy to address post-pandemic realities and emerging systemic risks.
• June 2024: WHO and Switzerland further deepen their specialized partnership by signing critical agreements to integrate Swiss research and logistical networks into the global BioHub system, enhancing international pathogen-sharing capabilities.
• March 4, 2025: The renewed WHO-Switzerland Cooperation Strategy for 2024–2028 is formally finalized and signed at the WHO Regional Office for Europe in Copenhagen, Denmark, by WHO Regional Director Dr. Hans Henri P. Kluge and Swiss Global Health Ambassador Barbara Schedler.

Core Pillars of the 2024–2028 Cooperation Strategy

The newly adopted cooperation strategy outlines a comprehensive, forward-looking roadmap structured around several strategic priorities designed to address contemporary public health challenges across Europe and globally.

1. Strengthening Health Security and Emergency Preparedness

Drawing hard-earned lessons from the COVID-19 pandemic, the strategy places renewed emphasis on cross-border health security. This includes enhancing early warning systems, improving laboratory diagnostic capacities, and ensuring rapid response mechanisms for future health emergencies. Switzerland’s advanced scientific infrastructure and centralized coordination networks will play an integral role in supporting European regional health security frameworks.

2. Advancing Global Health Innovation and the BioHub System

A critical component of the renewed partnership involves leveraging Swiss scientific excellence to support global health infrastructure. Building upon the strategic alignment established in mid-2024 regarding the global BioHub system, the 2024–2028 strategy prioritizes secure, transparent sharing of biological materials and pathogens of pandemic potential. This initiative ensures that the global scientific community can rapidly develop countermeasures, vaccines, and diagnostics in response to emerging biological threats.

3. Addressing Non-Communicable Diseases and Mental Health

While acute health emergencies frequently dominate headlines, chronic conditions and mental health challenges continue to place an immense burden on healthcare systems throughout the European region. The cooperation strategy outlines joint initiatives to implement evidence-based prevention policies, reduce risk factors associated with tobacco, alcohol, and poor diet, and integrate mental health support more effectively into primary healthcare delivery.

4. Promoting Universal Health Coverage and Equity

Ensuring equitable access to quality health services remains a foundational pillar of the WHO-Switzerland partnership. The strategy emphasizes strengthening health workforce resilience, optimizing resource allocation, and utilizing digital health innovations to bridge healthcare gaps, ensuring that vulnerable populations are not left behind.

Official Statements and Stakeholder Perspectives

The formalization of the agreement drew enthusiastic responses from leadership figures on both sides, underscoring the mutual commitment to multilateralism and global health solidarity.

Dr. Hans Henri P. Kluge, WHO Regional Director for Europe, highlighted the enduring value of the partnership during the signing ceremony in Copenhagen: "Switzerland has consistently demonstrated visionary leadership in global public health. By renewing our cooperation strategy through 2028, we are not only honoring a decade of productive collaboration, but we are also proactively shaping a more resilient, equitable, and secure future for public health across the European region and beyond."

Ambassador Barbara Schedler, speaking on behalf of the Swiss Federal Office of Public Health, emphasized Switzerland’s dedication to strengthening international health governance: "Our partnership with the World Health Organization is a cornerstone of Switzerland’s global health foreign policy. As we navigate an increasingly complex international landscape, maintaining strong, collaborative frameworks with multilateral institutions like the WHO is essential for safeguarding domestic populations and contributing meaningfully to global health security and innovation."

Broader Impact and Implications for Global Health Architecture

The continuation of the WHO-Switzerland Country Cooperation Strategy carries significant implications for the broader landscape of international health diplomacy. At a time when multilateral institutions face intense geopolitical pressures and funding uncertainties, the enduring commitment between Switzerland and the WHO serves as a powerful validation of the efficacy of international cooperation.

Furthermore, by utilizing a high-income nation framework, Switzerland continues to model responsible global citizenship. The strategy demonstrates that wealthy nations can—and should—actively participate in structured regional planning with global health bodies, rather than viewing international organizations merely as aid agencies for developing countries.

The integration of advanced research facilities, such as those supporting the global BioHub system, directly addresses historical bottlenecks in pathogen sharing and countermeasure development. By ensuring that Switzerland’s robust biotechnology and epidemiological infrastructure is tightly coordinated with WHO’s global surveillance networks, the partnership significantly enhances the collective defensive posture of the international community against future pandemics.

As the 2024–2028 strategy moves from planning into active implementation, the international public health community will closely monitor its execution. The success of this renewed framework is expected to inspire other high-income nations to formalize deeper, more structured partnerships with the WHO, ultimately fostering a more cohesive, responsive, and resilient global health architecture for the decades ahead.